USPTO serial 87449924
ALS PATHWAYS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 26, 2019
- Examiner
- CANTONE, KERI H
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with ALS PATHWAYS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Jersey City, NJ, US
JERSEY CITY, NJ, US
Mitsubishi Tanabe Pharma America, Inc.
Jersey City, NJ, US
Other trademarks owned by Mitsubishi Tanabe Pharma America, Inc.
Jersey City, NJ, US
Mitsubishi Tanabe Pharma America, Inc.
Jersey City, NJ, US
Other trademarks owned by Mitsubishi Tanabe Pharma America, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph Sherinsky
Joseph Sherinsky MITSUBISHI CHEMICAL AMERICA, INC.420 Lexington Avenue, Suite 428NEW YORK, NY 10170United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Providing medical information for patient and healthcare professional education in the area of amyotrophic lateral sclerosis (ALS); providing interactive and digital information in the fields of disease state and medicine for patients and healthcare professionals in the area of amyotrophic lateral sclerosis (ALS) | ACTIVE | Aug 24, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MT Pharma America, Inc.
- Other trademarks owned by TANABE PHARMA AMERICA, INC.
- Other trademarks owned by Mitsubishi Tanabe Pharma America, Inc.
- Other trademarks owned by MT Pharma America, Inc.
- Other trademarks owned by Mitsubishi Tanabe Pharma America, Inc.
- Other trademarks in Class 044
- Similar marks named ALS PATHWAYS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 25, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 25, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 25, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 25, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 24, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 26, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 26, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 21, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 20, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 30, 2019 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 27, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Nov 27, 2018 | IROA | RESPONSE TO ITU OFFICE ACTION ENTERED | — |
| Nov 27, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 26, 2018 | INCS | ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE | — |
| Nov 26, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 2, 2018 | IUAF | USE AMENDMENT FILED | — |
| Nov 2, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 8, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 13, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 13, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 21, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 30, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 11, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 10, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 9, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 19, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 18, 2017 | NWAP | NEW APPLICATION ENTERED | — |